

Indian Immunologicals Profile
Key Indicators
- Authorised Capital ₹ 400.00 Cr
- Paid Up Capital ₹ 54.00 Cr
- Company Age 25 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 335.16 Cr
- Satisfied Charges ₹ 887.42 Cr
- Revenue Growth 9.74%
- Profit Growth 239.81%
- Ebitda 164.63%
- Net Worth 25.26%
- Total Assets 8.79%
About Indian Immunologicals
Indian Immunologicals Limited (IIL) is a leading Public Limited Indian Non-Government Company incorporated in India on 08 October 1999 and has a history of 25 years and five months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 400.00 Cr and a paid-up capital of Rs 54.00 Cr.
The company currently has active open charges totaling ₹335.16 Cr. The company has closed loans amounting to ₹887.42 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Indian Immunologicals Limited India are Appalaraja Ganasala as CFO and Shuchi Sharma as Company Secretary. Agnihotra Chavali, Kinnera Bhagavatula, Meeneshkumar Shah, and Five other members serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U72200TG1999PLC032666
- Company No.
032666
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Oct 1999
- Date of AGM
17 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Indian Immunologicals Limited offer?
Indian Immunologicals Limited offers a wide range of products and services, including Animal Medicines & Health Care, Animal Treatment Services, Medical Consultants & Clinics, Health Care Service, Pet Care, Pet Grooming, Popular Category, Stomach Care.
Who are the key members and board of directors at Indian Immunologicals?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Anand Kanakasapapathy ![]() | Managing Director | 01-Nov-2013 | Current |
Appalaraja Ganasala ![]() | CFO | 01-Jul-2017 | Current |
Shuchi Sharma ![]() | Company Secretary | 10-Jul-2017 | Current |
Board Members (7)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sanjay Mehendale ![]() | Director | 12-Mar-2018 | Current |
Kinnera Bhagavatula ![]() | Director | 18-Mar-2015 | Current |
Agnihotra Chavali ![]() | Director | 18-Mar-2015 | Current |
Meeneshkumar Shah ![]() | Director | 15-Jul-2021 | Current |
Devanand Pathayapura ![]() | Director | 12-Nov-2021 | Current |
Priyabrata Pattnaik ![]() | Whole-Time Director | 16-Jul-2021 | Current |
Financial Performance of Indian Immunologicals.
Indian Immunologicals Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 9.74% increase. The company also saw a substantial improvement in profitability, with a 239.81% increase in profit. The company's net worth Soared by an impressive increase of 25.26%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Indian Immunologicals?
In 2023, Indian Immunologicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Vidya Dairy
Meeneshkumar Shah is a mutual person
- Vbc Industries Ltd
Kinnera Bhagavatula is a mutual person
- Idmc Limited
Meeneshkumar Shah and Rajeev Sivarama are mutual person
- Kalyan Jewellers India Limited
Agnihotra Chavali is a mutual person
- Pokarna Limited
Agnihotra Chavali is a mutual person
- Nddb Dairy Services
Meeneshkumar Shah and Devanand Pathayapura are mutual person
Charges (Loans)
₹335.16 Cr
₹887.42 Cr
Charges Breakdown by Lending Institutions
- Others : 215.16 Cr
- Hdfc Bank Limited : 120.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
05 May 2016 | Others | ₹5.00 Cr | Open |
18 Mar 2016 | Others | ₹85.16 Cr | Open |
12 Dec 2013 | Others | ₹40.00 Cr | Open |
14 Dec 2011 | Others | ₹85.00 Cr | Open |
02 Sep 2010 | Hdfc Bank Limited | ₹120.00 Cr | Open |
How Many Employees Work at Indian Immunologicals?
Unlock and access historical data on people associated with Indian Immunologicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Indian Immunologicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indian Immunologicals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Indian Immunologicals
Recent activity within the organization
- Annual General Meeting
Indian Immunologicals Limited last Annual general meeting of members was held on 17 Sep 2024 as per latest MCA records.
- Balance Sheet
Indian Immunologicals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
- Charges
A charge with Others of Rs. 5.00 Cr registered on 05 May 2016 with Charge ID 100031486 was modified on 15 Mar 2024.
- Charges
A charge with Others of Rs. 85.00 Cr registered on 14 Dec 2011 with Charge ID 10327282 was modified on 15 Mar 2024.
- Charges
A charge registered on 08 Feb 2016 via Charge ID 100016417 with Others was fully satisfied on 12 Dec 2022.
- Charges
A charge with Others of Rs. 85.16 Cr registered on 18 Mar 2016 with Charge ID 100024550 was modified on 31 Oct 2022.
Recent News, Updates & Announcement
- IIL begins construction of Rs 700 crore facility to make FMD vaccines.
The brand-new unit will have a BSL3 facility for the manufacture of drug substances and a fill-finish capability for the production of both drug products FMD vaccine and the FMD+HS vaccine..
Frequently asked questions
What is the Incorporation or founding date of Indian Immunologicals Limited?
Indian Immunologicals Limited was incorporated on 08 Oct 1999.
What is authorized share capital and paid-up capital of Indian Immunologicals Limited?
The authorized share capital of Indian Immunologicals Limited is ₹ 400.00 Cr and paid-up capital is ₹ 54.00 Cr.
Who are the current board members & directors of Indian Immunologicals Limited?
Currently 10 directors are associated with Indian Immunologicals Limited.
- Agnihotra Dakshina Murty Chavali
- Kinnera Murthy Bhagavatula
- Meeneshkumar Champaklal Shah
- Anand Kumar Kanakasapapathy
- Devanand Chakkingal Pathayapura
- Sanjay Madhav Mehendale
- Priyabrata Pattnaik
- Rajeev Sivarama
- Appalaraja Sekhar Ganasala
- Shuchi Sharma
What is the registered address of Indian Immunologicals Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Indian Immunologicals Limited is Indian Immunologicals Limited Road No. 44, Jubilee Hills India, Hyderabad, Telangana, 500033.
What is the corporate identification number (CIN) and company number of Indian Immunologicals Limited?
The corporate identification number (CIN) of Indian Immunologicals Limited is U72200TG1999PLC032666 and the company number is 032666 as per Ministry of Corporate Affairs (MCA).
What is the official website of Indian Immunologicals Limited?
The Official website of Indian Immunologicals Limited is https://www.indimmune.com
What has been the recent revenue trend for Indian Immunologicals Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Indian Immunologicals Limited has risen by 9.74%.
What change has been observed in the net worth of Indian Immunologicals Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Indian Immunologicals Limited has experienced an upsurge of 25.26%.
What are the total open charges for Indian Immunologicals Limited?
As per the financial statements for fiscal Year 2022, The total open charges for Indian Immunologicals Limited amount to ₹ 335.16 Cr.
When was the last Balance Sheet of Indian Immunologicals Limited filed with the ROC?
The most recent Balance Sheet for Indian Immunologicals Limited was filed with the ROC on 31 Mar 2024.
People also Viewed
- Varsha JoshiAdditional Director
- Tharavanat NandaDirector
BK
Balasubramaniam KollengodeManaging DirectorDT
Deepak TikkuDirectorVS
Villuppanoor SrinivasanDirectorAS
Akkapeddi SarmaDirectorAP
Amrita PatelDirectorPG
Padmanaban GovindarajanDirector